Pharmacology In Drug Discovery And Development

Hits are rarely suitable to become immediate drug candidates. They often suffer from weak binding affinity, poor stability, or off-target reactivity. Pharmacologists collaborate closely with medicinal chemists to iteratively modify the molecule's chemical structure. This phase optimizes key pharmacological parameters:

is the pharmacological surveillance of a drug's safety profile on a population scale. It uses signal detection to identify unexpected PK/PD interactions (e.g., a new drug raises the levels of a common blood thinner, causing bleeding). pharmacology in drug discovery and development

Once a potential drug (hit) is found, pharmacology-driven Structure-Activity Relationship (SAR) studies help optimize its potency and specificity. 2. Preclinical Development: Safety and Disposition Hits are rarely suitable to become immediate drug candidates

Two pillars support all drug discovery efforts: pharmacology in drug discovery and development